Business Description
UCB is a Belgium-based medical company founded in 1925 that focuses on developing treatments for people living with neurological and immune system conditions. Its portfolio includes medicines for epilepsy, Parkinson's disease, rheumatoid arthritis, psoriasis, osteoporosis, and several rare disorders, among others. The company also has a number of new treatments in development targeting conditions such as Alzheimer's disease, lupus, and chronic lung disease, while additionally providing contract manufacturing services to other organizations.